Day: November 4, 2022

BEIJING, Nov. 4, 2022 /PRNewswire/ — PowerChina’s regional headquarters business in the middle east and north Africa covers 20 countries, 59 projects are being implemented in 13 countries, and its total number of employees is 20,604. According to the ENR’s 2022 Top 250 International Contractors, PowerChina ranked in front, as the world’s largest engineering contractor in firmly in place.

Bringing hope to out-of-school Iraqi children

On the morning of June 18, PowerChina held the groundbreaking ceremony of PowerChina’s Iraqi Model School Project in Baghdad Province, Iraq. Iraqi Prime Minister Mustafa Qadimi attended it. PowerChina’s construction projects on the Iraqi model schools include building 679 schools in 10 governorates in Iraq flooring an area of 198,230m².

Bringing clean energy to the Iraqi people

The Iraqi Rumaila combined-cycle power plant project implemented by PowerChina is the first power plant project in Iraq funded by a Chinese company after the war, with a total installed capacity of 707 megawatts, equipped with two power zones. The two units of the project were completed and commissioned in April 2022, and operated smoothly to supply safe, reliable, and clean power to the grid in southern Iraq. So far, the Rumaila Power Plant has provided more than one billion kilowatt-hours of electricity, which has greatly alleviated the problem of electricity shortage and improved the livelihood of residents.

Enhancing “Saudi Vision 2030”

The King Salman Global Maritime Industries Complex project implemented by PowerChina is the world’s largest tanker port construction project and one of the main projects of Saudi Vision 2030. After the project has been completed, the port will become the world’s largest shipyard, with the ability to manufacture and repair supertankers and offshore rigs, which will help Saudi achieve the strategic goal of “Self-transportation of oil and manufacture of tankers”.

The Saudi Red Sea Utility and Infrastructure project is also part of the Saudi Vision 2030. It is the first large-scale commercial utility project in the world to integrate complementary multi-energy solutions. The project focuses on clean energy and environmental protection to achieve a green and pollution-free energy supply. The Red Sea Development Company, which is wholly owned by the Public Investment Fund, is the final off-taker for the Red Sea project.

Warming the hearts of the Saudi people

As of June 2022, there were 1,757 Saudi employees in PowerChina’s Saudi Arabia business unit. PowerChina provides health checkups, vaccinations, Covid-19 PCR testing, psychological counseling, and other health services for its employees, which are well received and appreciated by all employees.

In addition, PowerChina attaches great importance to cross-cultural communication among employees. It respects the traditions of Muslims and established prayer spaces at all construction sites of all its projects. At the same time, Chinese employees introduce employees and local people to traditional Chinese culture and the gorgeous achievements of modern China, which has effectively enhanced the international image of China.

Photo – https://mma.prnewswire.com/media/1937964/image1.jpg

BEIJING, Nov. 4, 2022 /PRNewswire/ — Power Construction Corporation of China (PowerChina) is actively participating in the “Belt and Road” initiative in Africa, responding to the planning and demand of African countries.

Promoting the localization 

At PowerChina, African staff plays a significant role. Employment is a key issue in African countries, especially women’s right to work. Two female Caterpillar drivers are able to earn a dignified living since their collaboration with the PowerChina at the rehabilitation site of Lot 2 of National Road 4 in Cameroon. Such examples are not uncommon. After finishing school in China in 2014, Kilenga Nelly managed to be recruited by the Zongo II hydroelectric power plant project once she returned to the Democratic Republic of Congo (DRC), allowing her to contribute to the development of her own country.

In April, the company organized the first job fair in the DRC, at the University of Kinshasa, during which more than 90 students submitted their CVs. It is worth noting that some local employees are now in management positions. Young Cameroonian Ngangoua Serge started at PowerChina as an intern in 2008. After his doctoral studies in China in 2010, he assisted in establishing an office in his country and five years later, he was appointed as PowerChina’s representative in Cameroon.

Serving socio-economic development 

To achieve its Vision 2035 of becoming an emerging nation, Cameroon planned hydro power plants in 2009 to address the electricity shortage. PowerChina succeeded in taking charge of the construction of the Memve’ele hydroelectric power plant. PowerChina has also built roads here. The Mintom-Lélé section has changed the daily lives of the local population, facilitating the local transport of people and goods, and has greatly stimulated economic activity.

“Three Gorges Dam of West Africa”, the Soubré hydroelectric plant, whose annual power generation capacity represents 43% of the country. It helps meet the huge demand for electricity and increase electricity exports to neighboring countries, becoming a new engine for economic development in West Africa. In 2021, the Gribo Popoli hydroelectric plant started construction.

Taking social responsibility 

PowerChina has a tradition of volunteering at schools, orphanages and neighborhood hospitals near construction sites. On December 22, 2018, the company’s volunteers in Ivory Coast gave about 100 children Christmas gifts worth 1 million CFA francs ($1,557). Besides, PowerChina has joined the fight against the COVID-19 with the local community. Volunteers from the Zongo II hydropower project held an epidemic prevention presentation event at a school in the village of Zongo in the DRC in May 2020. The volunteers also used vehicles to spread messages to prevent the epidemic. They drove through more than 10 villages in the DRC, making more than 30 presentations, covering more than 30,000 people.

Photo – https://mma.prnewswire.com/media/1937951/Gaston_Eloundou_Essomba_Cameroon_s_Minister_Water_Energy__second_right__accompanied.jpg

BANGKOK, Nov. 4, 2022 /PRNewswire/ — The 8th Ultra-Broadband Forum (UBBF 2022) was held in Bangkok, Thailand from October 24 to 28, 2022. Huawei showcased multiple cutting-edge technologies of optical transport networks, demonstrating innovative service ideas and technical practices for global carriers.

As global digital services develop, optical private line services are widely used in various industries and scenarios. Optical private lines with high bandwidth, low latency, and high reliability have gradually set off a trend and become a common need in business scenarios.

Although the development of private line services varies from region to region, how to monetize OTN private lines has always been a major concern of global carriers. Therefore, Huawei equips iMaster NCE with innovative capabilities to improve the intelligence of optical networks and provide key monetization enablement for private line services.

As the technical core of the OTN network system, Huawei iMaster NCE provides full-service-lifecycle support for carriers’ private line monetization. It not only provides basic service provisioning and alarm monitoring functions, but also supports sales through ACTN NBIs, helping carriers improve efficiency and increase revenue.

In the private line sales expansion phase, carriers can quickly query the minimum latency of private lines based on the latency map from iMaster NCE, ensuring customers’ latency and bandwidth requirements are fully met and improving the service matching efficiency. In addition, with the online visualization and automatic recommendation functions of private line availability, carriers can accurately filter for high-reliability private lines that meet the customer’s further requirements.

In the service provisioning phase, StellarGo, an innovative technology, implements customer SLA requirement satisfaction and improves the efficiency of OTN private line provisioning. It trains a path calculation and recommendation model based on expert experience and massive data, which can implement multi-factor, multi-policy intelligent path selection instead of the single-factor, single-policy path selection in the past. In addition, it provides personalized recommendations based on the SLA requirements of customers. It has been verified that the path calculation success rate reaches 99% and the service provisioning efficiency is improved by 70%. With the help of better recommendation algorithms, customers can obtain higher-quality private line services.

In the service O&M phase, the private line SLA assurance capability helps carriers monitor key service performance indicators in real time so as to identify and avoid service SLA risks promptly. In addition, Huawei’s reliability commitment also contributes to monetization of customers’ private lines. By enabling ASON at the network layer, as well as intelligent incident management and fault forecast at the NMS layer, carriers can quickly identify root causes of faults, locate faults, and constantly provide highly reliable and zero-fault network services.

Huawei experts conclude that the improvement of automation and intelligence capabilities will be an essential step for carriers’ business success. Huawei believes that through the collaboration and continuous exploration, the premium connection of optical networks will benefit various industries and become a cornerstone of development in the digital era.

Revolutionary atomic-scale imaging has enabled non-destructive real-time observation of biomolecules within a protein in motion, the observation revealed how proteins use multi-frequency vibrations to change their shapes and functions, this new technology aims to revolutionize nothing less than drug development itself, dramatically reducing time and costs; understanding how life functions at the smallest scales can become our most powerful tool in the fight against all diseases—and the ability to identify underlying disease mechanisms.

DUBAI, UAE, Nov. 4, 2022 /PRNewswire/ — RAM Medical CorporationL.L.C. (RMC), based in UAE and Germany, has recently set up its headquarters in Dubai. For the past several years, RMC has been developing the next generation of biosensors for biomedical applications. As of October 2022, RMC innovation has created an IP portfolio of more than 60 sensor patents and operates its R&D facilities, cleanrooms, and research labs in Germany. The Company has developed a revolutionary 3D biomolecular mapping platform called ThEA (Terahertz Express Analyzer) for real-time 3D imaging of proteins in hopes of radically changing the drug development and personalized diagnostics industries.

A new perspective on “the small things”

RMC has been at the forefront of biotechnology breakthroughs in 3D structural imaging on the atomic scale. RMC’s biomolecular imaging platform ThEA was the first non-destructive technology to produce three-dimensional (3D) atomic-scale maps of entire portions of proteins in real-time. Recently, RMC announced a critical development that enables the 3D mapping of the entire inner and outer composition of proteins, including their higher-order structures.

Now, for the first time, our researchers can visualize the dynamic motions of individual protein segments, as well as the entire protein’s movements in biological samples. Considered one of the greatest challenges in structural biology or an impossible task by others, RMC is excited to announce the upcoming Q4 2022 ThEA product launch.

This new technology can reduce diagnostic testing times for disease detection to a matter of seconds! The ThEA technology has already been independently tested and clinically validated through patient trials in several countries (including Israel, Germany, and Saudi Arabia), and has received “CE” regulatory approval for clinical diagnostics of multiple viral pathogens throughout Europe.

The drug revolution starts here

Only 20% of new drugs successfully complete clinical trials, while timelines surpass 10 years, costing over $2 billion for a market-ready drug.

“In silico modeling,” such as those used to artificially model proteins and cells for drug development applications, have resulted in substantial numbers of false leads for drug developers, and are known to produce flawed 3D protein models and predictions when compared to biomolecular imaging techniques.

In contrast, ThEA’s 3D protein-mapping platform uses non-destructive sensors to map the entire protein’s outer and inner sub-structures, with a resolution of individual atoms. It will be the first time 3D structural transitions can be mapped and observed in proteins providing considerable insight for drug development and diagnostic applications.

The key to the ThEA technology is the application of patented Terahertz (THz) and Infrared (IR) sensors that detect, match, and combine a series of optical resonances and vibrational modes that are naturally occurring in proteins, and are translated into a 3D map of the protein.

“It was believed that having the ability to image proteins at a resolution of individual atoms was the holy grail in structural biology,” says Ayal Ram, the visionary CEO of RMC “however, observing a protein in action is the key to truly transforming the drug development, precision medicine, and personalized diagnostics industries.”

Small and intelligent

The ThEA platform uses AI-machine-learning models that combine both the physical and virtual to produce new functional drugs that will address unique disease models on an individual basis and enable tailoring drug designs to an individual’s ThEA-identified “underlying disease condition.”

The advancements in AI will fulfill a key role in discovering the best disease attack vectors for doctors, improving the decision-making process, and helping fill gaps in unknown disease models, and suggesting novel treatments.

Nothing less than the corona pandemic has given proof of ThEA’s disruptive platform with the capability to quickly develop and validate diagnostic tools for rapid disease detection, and diagnosis of individual disease mechanisms. “Using our ThEA platform based on a chemical-free and reagent-free direct detection method, we could differentiate infectious from non-infectious Covid-19 patients by analyzing the structures of three Covid-19 viral proteins and their collective 3D structures simultaneously—a capability not possible with any other technology.

Breaking down barriers to healthcare access

Recently, RMC developed two rapid diagnostic tests for Covid-19 and Influenza A/B with an all-in-one single test. The clinical results for both Covid-19 and Influenza were outstanding, achieving an overall accuracy equivalent to RT-PCR testing methods based on independent clinical studies and validations,” says Ayal Ram. “To date, RMC’s ThEA’s RapiDx Covid-19 Test continues to be the fastest diagnostic test for pathogens diagnostics worldwide, with a total measurement time of only 30 seconds.”

RAM was awarded the XPRIZE for its Covid-19 Test (a winner, and one of the four winning teams in the XPRIZE Rapid Covid-19 Testing Competition in 2021, “RAM ThEA platform announced a winner of XPRIZE Open Innovation Track“), also received CE regulatory approval, and is listed on the European Database on Medical Devices “EUDAMED,” (link: ThEA Device Analyzer and the link: ThEA Rapid Sensor), and is officially listed on the approved EU COVID-19 In Vitro Diagnostic Devices and Tests Database.

It’s crystal clear

Independent human clinical trials in Israel for Covid-19 results: Overall accuracy of 97.8% (Sensitivity 95.1%, Specificity 98.6%); and the independent human clinical trials in Israel for Influenza A/B results: Overall accuracy of 98.5% (Sensitivity 97.3%, Specificity 100%).

With the validation of its ThEA platform, RAM Medical Corporation is addressing a $60 bn laboratory equipment market, expected to continue having a double-digit growth over the next ten years.

About RMC: Ram Medical Corporation LLC, was founded by (a cancer survivor) Ayal Ram with the life goal of revolutionizing the biomedical diagnostic sector. RMC has a strong multi-disciplinary team who develop a wide array of biosensors for novel applications for over a decade. “We are constantly looking for ways to integrate our technologies to create new product platforms and disruptive applications.” says Ayal Ram, whose life and work motto is “All you can imagine is possible! It just has not been invented yet.”

Contact Details:

For Press & Media, email us @:
press@rammedical.ae or press@ramthzsolutions.com

For Business Opportunities or Product Details:
contact@rammedical.ae or contact@ramthzsolutions.com

For direct contact, call: +49-681-3096-4800
www.ramsolutions.com or www.ramglobal.com

Photo – https://mma.prnewswire.com/media/1937739/RAM_Medical_Corporation_A_ThEA_platform_map.jpg